Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lyophilization Services of New England (LSNE) announced the acquisition of a sterile injectables manufacturing facility located in León, Spain.
read more
Cambrex has completed a new 600 m2 facility at its site in Karlskoga, Sweden, which incorporates new laboratories for process and analytical development.
read more
REGENXBIO has selected Skyland PIMS Process Information Management Suite for management and analysis of product, process and patient data throughout their development and manufacturing supply chain.
read more
IVERIC bio and Catalent Biologics have entered into an agreement for production and manufacturing of GMP-grade AAV vector for IVERIC bio’s gene therapy product candidates, IC-100.
read more
Lannett has informed the approximately 80 employees at its Cody Labs subsidiary it has decided to cease operations and close its facility in Wyoming.
read more
Baxter announced receipt of a major R&D grant from the German BMBF’s “From Material to Innovation” program to lead a consortium investigating an anticoagulation-free HD option for ESRD.
read more
Bellwyck Pharma Services continues to invest in its global reach and capabilities with a recent facility expansion.
read more
Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1.
read more
IQVIA™ announced that Ferring Pharmaceuticals has selected IQVIA Technologies’ OCE platform for global deployment across more than 50 markets.
read more
Dr. Reddy’s has entered into a purchase agreement with Upsher-Smith Laboratories, pursuant to which the company would sell its US and select territory rights for ZEMBRACE®, SYMTOUCH®, and TOSYMRA™.
read more
Exploristics, has announced plans to launch an updated version of its cloud-based data analytics platform for clinical trial design, KerusCloud 2.0, by the end of the summer.
read more
Camargo Pharmaceutical Services announced it will acquire InSymbiosis, a Canadian drug development partner which improves how biopharma companies outsource R&D.
read more
Lonza announced an investment in a major expansion of Highly Potent API (HPAPI) capacity at its Visp, CH site.
read more
Signant Health, formerly CRF Bracket, has appointed Lawrence Miller as Chief Technology Officer.
read more
On 22 May 2019 Amgen announced a recommended public cash offer to the shareholders of Nuevolution to tender all their shares in Nuevolution to Amgen for SEK 32.50 per share in cash.
read more